The leading contrast agent company Guerbet recently launches the OptiVantage multi-use contrast media injector, which is CE marked. This injector system is designed for injecting contrast media agents used in computed tomography (CT) examinations.
The new solution includes the OptiVantage syringe-based injector, a complete range of associated syringes and disposables (manyFill day set and secufill patient line), services and support systems (OptiProtect).
OptiVantage multi-use injector will be initially marketed in Europe, the Middle East and Africa region (EMEA) from January 2019, then progressively in other regions of the world (Asia and Latin America).
The existing OptiVantage customers may benefit from an upgrade to easily implement the new multi-use feature.
Launched in 2005, the OptiVantage injector is a Class IIb medical device intended for use by medical imaging and diagnostic health professionals, for injecting contrast media and saline into a patient's vascular system during CT examinations. The new version is adapted to multi-use markets and is available in both pedestal and ceiling-mount versions.
For more information please go to the website: www.guerbet.com
